RGS2 [The Human Chemical-Genetic Interaction Map Project]

This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong.
======= RGS2 =======


== Gene Information ==
  * **<color #00a2e8>Official Symbol</color>**: RGS2
  * **<color #00a2e8>Official Name</color>**: regulator of G protein signaling 2
  * **<color #00a2e8>Aliases and Previous Symbols</color>**: N/A
  * **<color #00a2e8>Entrez ID</color>**: [[https://www.ncbi.nlm.nih.gov/gene/?term=5997|5997]]
  * **<color #00a2e8>UniProt</color>**: [[https://www.uniprot.org/uniprot/P41220|P41220]]
  * **<color #00a2e8>Interactions</color>**: [[https://thebiogrid.org/search.php?search=RGS2&organism=9606|BioGRID]]
  * **<color #00a2e8>PubMed articles</color>**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20RGS2|Open PubMed]]
  * **<color #00a2e8>OMIM</color>**: [[https://omim.org/entry/600861|Open OMIM]]

== Function Summary ==
  * **<color #00a2e8>Entrez Summary</color>**:  Regulator of G protein signaling (RGS) family members are regulatory molecules that act as GTPase activating proteins (GAPs) for G alpha subunits of heterotrimeric G proteins. RGS proteins are able to deactivate G protein subunits of the Gi alpha, Go alpha and Gq alpha subtypes. They drive G proteins into their inactive GDP-bound forms. Regulator of G protein signaling 2 belongs to this family. The protein acts as a mediator of myeloid differentiation and may play a role in leukemogenesis. [provided by RefSeq, Aug 2009]. 
  * **<color #00a2e8>UniProt Summary</color>**:  Regulates G protein-coupled receptor signaling cascades. Inhibits signal transduction by increasing the GTPase activity of G protein alpha subunits, thereby driving them into their inactive GDP-bound form (PubMed:11063746, PubMed:19478087). It is involved in the negative regulation of the angiotensin-activated signaling pathway (PubMed:28784619). Plays a role in the regulation of blood pressure in response to signaling via G protein-coupled receptors and GNAQ. Plays a role in regulating the constriction and relaxation of vascular smooth muscle (By similarity). Binds EIF2B5 and blocks its activity, thereby inhibiting the translation of mRNA into protein (PubMed:19736320). {ECO:0000250|UniProtKB:O08849, ECO:0000269|PubMed:11063746, ECO:0000269|PubMed:11278586, ECO:0000269|PubMed:17901199, ECO:0000269|PubMed:19736320, ECO:0000269|PubMed:28784619, ECO:0000305|PubMed:7643615}.

<button type='primary' size='sm' modal='Pfam_Domains'>Pfam Domains</button>
<button type='primary' size='sm' modal='GO_terms'>GO Terms</button>


<modal id='Pfam_Domains' size='lg' title='Pfam Domains'>
|RGS|
</modal>

<modal id='GO_terms' size='lg' title='GO Terms'>
|negative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process|
|regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process|
|regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway|
|negative regulation of glycine import across plasma membrane|
|regulation of glycine import across plasma membrane|
|negative regulation of neurotransmitter uptake|
|relaxation of vascular smooth muscle|
|regulation of amino acid import across plasma membrane|
|regulation of amino acid transmembrane transport|
|negative regulation of phospholipase activity|
|relaxation of smooth muscle|
|negative regulation of cell growth involved in cardiac muscle cell development|
|negative regulation of amino acid transport|
|positive regulation of cardiac muscle contraction|
|relaxation of cardiac muscle|
|positive regulation of striated muscle contraction|
|negative regulation of smooth muscle contraction|
|negative regulation of anion transmembrane transport|
|negative regulation of cardiac muscle cell differentiation|
|negative regulation of lipase activity|
|regulation of cell growth involved in cardiac muscle cell development|
|ovulation|
|regulation of neurotransmitter uptake|
|negative regulation of organic acid transport|
|negative regulation of cardiocyte differentiation|
|relaxation of muscle|
|negative regulation of cAMP-mediated signaling|
|negative regulation of cardiac muscle tissue growth|
|negative regulation of muscle contraction|
|negative regulation of neurotransmitter transport|
|negative regulation of heart growth|
|G-protein alpha-subunit binding|
|negative regulation of amine transport|
|negative regulation of cardiac muscle hypertrophy|
|regulation of anion transmembrane transport|
|brown fat cell differentiation|
|negative regulation of anion transport|
|negative regulation of muscle hypertrophy|
|negative regulation of response to drug|
|vasodilation|
|regulation of amino acid transport|
|negative regulation of organ growth|
|negative regulation of cardiac muscle tissue development|
|response to amphetamine|
|regulation of cardiac muscle cell differentiation|
|beta-tubulin binding|
|positive regulation of heart contraction|
|negative regulation of striated muscle cell differentiation|
|positive regulation of muscle contraction|
|response to amine|
|negative regulation of G protein-coupled receptor signaling pathway|
|negative regulation of striated muscle tissue development|
|negative regulation of muscle organ development|
|regulation of cAMP-mediated signaling|
|regulation of cardiocyte differentiation|
|negative regulation of muscle tissue development|
|response to bronchodilator|
|cytoplasmic side of plasma membrane|
|negative regulation of muscle cell differentiation|
|regulation of cardiac muscle hypertrophy|
|positive regulation of blood vessel diameter|
|regulation of organic acid transport|
|regulation of cardiac muscle tissue growth|
|regulation of muscle hypertrophy|
|regulation of smooth muscle contraction|
|regulation of heart growth|
|maternal process involved in female pregnancy|
|positive regulation of blood circulation|
|regulation of phospholipase activity|
|negative regulation of MAP kinase activity|
|regulation of cardiac muscle contraction|
|regulation of cardiac muscle tissue development|
|negative regulation of cation transmembrane transport|
|regulation of muscle adaptation|
|regulation of striated muscle contraction|
|regulation of amine transport|
|regulation of organ growth|
|negative regulation of ion transmembrane transport|
|regulation of anion transport|
|regulation of lipase activity|
|regulation of response to drug|
|regulation of striated muscle cell differentiation|
|negative regulation of developmental growth|
|fat cell differentiation|
|negative regulation of transmembrane transport|
|response to ethanol|
|negative regulation of translation|
|female gamete generation|
|regulation of striated muscle tissue development|
|negative regulation of protein serine/threonine kinase activity|
|regulation of muscle tissue development|
|regulation of muscle organ development|
|regulation of tube diameter|
|regulation of blood vessel diameter|
|regulation of tube size|
|regulation of neurotransmitter transport|
|regulation of G protein-coupled receptor signaling pathway|
|negative regulation of cellular amide metabolic process|
|negative regulation of ion transport|
|regulation of muscle cell differentiation|
|regulation of muscle contraction|
|negative regulation of MAPK cascade|
|vascular process in circulatory system|
|female pregnancy|
|negative regulation of cell growth|
|calmodulin binding|
|multi-multicellular organism process|
|negative regulation of protein kinase activity|
|response to alcohol|
|regulation of muscle system process|
|regulation of heart contraction|
|negative regulation of growth|
|negative regulation of kinase activity|
|negative regulation of transferase activity|
|positive regulation of neuron projection development|
|GTPase activator activity|
|regulation of blood circulation|
|muscle system process|
|response to xenobiotic stimulus|
|response to antibiotic|
|neuron projection|
|regulation of developmental growth|
|GTPase activity|
|negative regulation of cell development|
|regulation of cation transmembrane transport|
|regulation of MAP kinase activity|
|regulation of neurotransmitter levels|
|regulation of translation|
|positive regulation of neuron differentiation|
|positive regulation of cell projection organization|
|blood circulation|
|circulatory system process|
|regulation of cellular amide metabolic process|
|negative regulation of protein phosphorylation|
|positive regulation of GTPase activity|
|regulation of cell growth|
|negative regulation of phosphorylation|
|negative regulation of hydrolase activity|
|positive regulation of neurogenesis|
|regulation of ion transmembrane transport|
|regulation of GTPase activity|
|negative regulation of transport|
|regulation of neuron projection development|
|negative regulation of intracellular signal transduction|
|response to toxic substance|
|regulation of anatomical structure size|
|regulation of protein serine/threonine kinase activity|
|posttranscriptional regulation of gene expression|
|positive regulation of nervous system development|
|positive regulation of cell development|
|spermatogenesis|
|negative regulation of phosphate metabolic process|
|negative regulation of phosphorus metabolic process|
|regulation of transmembrane transport|
|male gamete generation|
|regulation of system process|
|negative regulation of protein modification process|
|regulation of neuron differentiation|
|regulation of growth|
|gamete generation|
|regulation of plasma membrane bounded cell projection organization|
|regulation of ion transport|
|regulation of cell projection organization|
|negative regulation of cell differentiation|
|brain development|
|regulation of MAPK cascade|
|positive regulation of hydrolase activity|
|head development|
|negative regulation of catalytic activity|
|regulation of protein kinase activity|
|regulation of neurogenesis|
|multicellular organismal reproductive process|
|sexual reproduction|
|multicellular organism reproduction|
|nucleolus|
|regulation of kinase activity|
|regulation of nervous system development|
|regulation of cell development|
|negative regulation of developmental process|
|positive regulation of cell differentiation|
|regulation of transferase activity|
|central nervous system development|
|multi-organism reproductive process|
|response to organonitrogen compound|
|response to drug|
|negative regulation of cellular protein metabolic process|
|response to nitrogen compound|
|negative regulation of protein metabolic process|
|negative regulation of molecular function|
|negative regulation of multicellular organismal process|
|positive regulation of cellular component organization|
|mitochondrion|
|negative regulation of signal transduction|
|regulation of hydrolase activity|
|G protein-coupled receptor signaling pathway|
|cell cycle|
|negative regulation of cell communication|
|negative regulation of signaling|
|positive regulation of developmental process|
|negative regulation of cellular macromolecule biosynthetic process|
|reproductive process|
|reproduction|
|positive regulation of catalytic activity|
|regulation of protein phosphorylation|
|negative regulation of macromolecule biosynthetic process|
|negative regulation of cellular biosynthetic process|
|generation of neurons|
|negative regulation of biosynthetic process|
|response to oxygen-containing compound|
|regulation of phosphorylation|
|negative regulation of response to stimulus|
|neurogenesis|
|negative regulation of gene expression|
|positive regulation of multicellular organismal process|
|positive regulation of molecular function|
|regulation of phosphate metabolic process|
|regulation of phosphorus metabolic process|
|regulation of cell differentiation|
|regulation of intracellular signal transduction|
|regulation of protein modification process|
|regulation of transport|
|system process|
</modal>
\\

 === CRISPR Data ===
<button type='primary' size='small' modal='Compound_Hit'>Compound Hit</button>
<button type='default' size='small' modal='Most_Correlated_Genes'>Most Correlated Genes in Chemogenomics</button>
<button type='primary' size='small' modal='Essential_Avana'>Tissues where Essential in the Avana Dataset (DepMap 20Q1)</button>

<modal id='Compound_Hit' size='lg' title='Compound Hit'>
^Screen^Score^
|[[:results:exp259|6-Thio-2-deoxyguanosine 2μM R06 exp259]]|-1.74|
</modal>

<modal id='Most_Correlated_Genes' size='lg' title='Most Correlated Genes in Chemogenomics'>
No correlation found to any other genes in chemogenomics.
</modal>

<modal id='Essential_Avana' size='lg' title='Tissues where Essential in the Avana Dataset (DepMap 20Q1)'>
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
</modal>

== Essentiality in NALM6  ==
    * **<color #00a2e8>Essentiality Rank</color>**: 18833
    * **<color #00a2e8>Expression level (log2 read counts)</color>**: 1.43 
<button type='primary' size='small' modal='Dist_expr'>Expression Distribution</button>
<modal id='Dist_expr' size='lg' title='RGS2 Expression in NALM6 Cells: 1.43'>
{{:chemogenomics:nalm6 dist.png?nolink |}}
</modal>